UNI-BIO GROUP (00690) Shareholders Deposit Shares Worth HK$113 Million into HSBC

Stock News

Sep 24

According to the latest data from the Hong Kong Stock Exchange, on September 23, shareholders of UNI-BIO GROUP (00690) deposited shares into HSBC with a market value of HK$113 million, representing 12.33% of the company's shares.

Recently, UNI-BIO GROUP announced that its wholly-owned subsidiary Beijing Bokang Jiankang Gene Technology Co., Ltd. has signed a strategic cooperation agreement with Sinovac Biotech Co., Ltd. Under this agreement, Sinovac has been granted exclusive commercial rights to market the group's innovative osteoporosis treatment drug Bogutai® in six countries within the cooperation region: Saudi Arabia, Egypt, Morocco, Colombia, Argentina, and Mexico.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1137980603"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1137980603\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1137980603?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-24 08:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137980603","market":"other","top_or_hot":-1,"title":"UNI-BIO GROUP (00690) Shareholders Deposit Shares Worth HK$113 Million into HSBC","media":"Stock News","content":"<p>According to the latest data from the Hong Kong Stock Exchange, on September 23, shareholders of UNI-BIO GROUP (00690) deposited shares into HSBC with a market value of HK$113 million, representing 12.33% of the company's shares.</p>\n<p>Recently, UNI-BIO GROUP announced that its wholly-owned subsidiary Beijing Bokang Jiankang Gene Technology Co., Ltd. has signed a strategic cooperation agreement with Sinovac Biotech Co., Ltd. Under this agreement, Sinovac has been granted exclusive commercial rights to market the group's innovative osteoporosis treatment drug Bogutai® in six countries within the cooperation region: Saudi Arabia, Egypt, Morocco, Colombia, Argentina, and Mexico.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UNI-BIO GROUP (00690) Shareholders Deposit Shares Worth HK$113 Million into HSBC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUNI-BIO GROUP (00690) Shareholders Deposit Shares Worth HK$113 Million into HSBC\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-09-24 08:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>According to the latest data from the Hong Kong Stock Exchange, on September 23, shareholders of UNI-BIO GROUP (00690) deposited shares into HSBC with a market value of HK$113 million, representing 12.33% of the company's shares.</p>\n<p>Recently, UNI-BIO GROUP announced that its wholly-owned subsidiary Beijing Bokang Jiankang Gene Technology Co., Ltd. has signed a strategic cooperation agreement with Sinovac Biotech Co., Ltd. Under this agreement, Sinovac has been granted exclusive commercial rights to market the group's innovative osteoporosis treatment drug Bogutai® in six countries within the cooperation region: Saudi Arabia, Egypt, Morocco, Colombia, Argentina, and Mexico.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1231","symbol_name":"综合性银行","start_time":0,"source_url":"","article_id":"1137980603","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137980603","pubTimestamp":1758673699,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"According to the latest data from the Hong Kong Stock Exchange, on September 23, shareholders of UNI-BIO GROUP (00690) deposited shares into HSBC with a market value of HK$113 million, representing...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1231":"综合性银行","00005":"汇丰控股","LU0052756011.USD":"TEMPLETON GLOBAL BALANCED \"A\" (USD) INC","BK4521":"英国银行股","LU0310800965.SGD":"FTIF - Templeton Global Balanced A Acc SGD","LU0164880469.USD":"HSBC GIF HONG KONG EQUITY \"AC\" ACC","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","BK1572":"香港银行股","BK4588":"碎股","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","LU0516422366.SGD":"Fullerton Lux Funds - Asia Focus Equities A Acc SGD","LU0540923850.HKD":"ALLIANZ HONG KONG EQUITY \"A\" (HKD) INC","LU1481107354.HKD":"HSBC GIF HONG KONG EQUITY \"AD\" (HKD) INC","BK4207":"综合性银行","LU0634319403.HKD":"ALLIANZ HONG KONG EQUITY \"AT\" (HKD) ACC","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","00690":"联康生物科技集团","LU0149721374.USD":"HSBC GIF HONG KONG EQUITY \"AD\" INC","BK1610":"ETF&股票定投概念","BK1161":"生物科技","HSBC":"汇丰","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC","BK1601":"香港本地股","03143":"华夏香港银行股","BK4585":"ETF&股票定投概念","HSHD.SI":"HSBC HK SDR 5to1","LU1267930227.SGD":"TEMPLETON GLOBAL BALANCED \"AS\" (SGD) ACC A","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","HSBA.UK":"汇丰控股有限公司","LU0128525689.USD":"TEMPLETON GLOBAL BALANCED \"A\"(USD) ACC"},"translate_title":"联康生物集团(00690)股东将价值1.13亿港元股份存入汇丰","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00005":1,"00690":1,"03143":1,"HSHD.SI":1,"HSBC":1,"HSBA.UK":1},"content_text":"According to the latest data from the Hong Kong Stock Exchange, on September 23, shareholders of UNI-BIO GROUP (00690) deposited shares into HSBC with a market value of HK$113 million, representing 12.33% of the company's shares.\nRecently, UNI-BIO GROUP announced that its wholly-owned subsidiary Beijing Bokang Jiankang Gene Technology Co., Ltd. has signed a strategic cooperation agreement with Sinovac Biotech Co., Ltd. Under this agreement, Sinovac has been granted exclusive commercial rights to market the group's innovative osteoporosis treatment drug Bogutai® in six countries within the cooperation region: Saudi Arabia, Egypt, Morocco, Colombia, Argentina, and Mexico.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}